Author
Won‐Jun Shon
Recent research
- Health & MedicineOpen access
Abstract Introduction Denosumab is a potent RANKL inhibitor used for osteoporosis, yet its impact on root canal treatment (RCT) outcomes remains less understood compared to bisphosphonates. This study evaluated the periapical healing outcomes of RCT in patients receiving denosuma...